How Lipitor Works on HMG-CoA Reductase
Lipitor (atorvastatin) blocks HMG-CoA reductase, the liver enzyme that makes cholesterol. By inhibiting it, Lipitor cuts cholesterol production, prompting the liver to pull more LDL cholesterol from the blood.[1]
Why This Lowers Cholesterol Levels
HMG-CoA reductase converts HMG-CoA into mevalonate, a key step in cholesterol synthesis. Lipitor competes at the enzyme's active site, slowing the pathway and reducing total and LDL cholesterol by 20-60% depending on dose.[2][1]
What Happens Without Lipitor's Inhibition
Without blockade, the enzyme runs freely, leading to excess cholesterol buildup in arteries (atherosclerosis). Patients with high cholesterol often have overactive HMG-CoA reductase activity.[3]
Common Analogy for Patients
Think of HMG-CoA reductase as a factory conveyor belt churning out cholesterol bricks. Lipitor jams the belt at the start, so fewer bricks pile up and the body clears extras from the bloodstream.[1]
[1]: FDA Label for Lipitor
[2]: DrugPatentWatch.com - Atorvastatin Mechanism
[3]: PubMed - Statin Mechanism Review